FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164824871> ?p ?o ?g. }

• W2164824871 endingPage "11" @default.
• W2164824871 startingPage "605" @default.
• W2164824871 abstract "Osteopontin (OPN) is a secreted, integrin-binding phosphoprotein that has been implicated in both normal and pathological processes; qualitative increases in OPN blood levels have been reported in a small number of patients with metastatic tumors of various kinds. We measured plasma OPN levels in 70 women with known metastatic breast carcinoma, 44 patient controls who were on follow-up after completion of adjuvant treatment for early breast cancer, and 35 normal volunteers. The median plasma OPN of patients with metastatic disease was 142 microgram/liter (range, 38-1312 microgram/liter) and was significantly different (P < 0.0001, Mann Whitney U test) from both control groups (medians, 60 and 47 microgram/liter; ranges, 15-117 and 22-122 microgram/liter). Furthermore, we found that increasing plasma OPN is associated with shorter survival (P < 0.001) when patients were grouped in terciles for plasma OPN. This was also demonstrated when using a Cox proportional hazards model. Median plasma OPN levels were significantly increased for three or more sites of involvement (median, 232 microgram/liter; n = 13) versus 1 or 2 metastatic sites (medians, 129 and 130 microgram/liter; n = 29 and 28, respectively). Plasma OPN levels were correlated with other biochemical markers related to the extent of disease, such as serum alkaline phosphatase, aspartate succinate aminotransaminase, and albumin (r = 0.81, 0.62, and -0.56, respectively; all P < 0.001). This study demonstrates a statistically significant elevation in plasma OPN in the majority ( approximately 70%) of a large series of patients with metastatic breast cancer when compared (95th percentile) to healthy women or patients who had completed adjuvant treatment for early-stage breast cancer. Furthermore, this is the first study to demonstrate that higher OPN levels in patients with metastatic breast cancer may be associated with an increased number of involved sites and decreased survival." @default.
• W2164824871 created "2016-06-24" @default.
• W2164824871 creator A5000409705 @default.
• W2164824871 creator A5001630082 @default.
• W2164824871 creator A5010151617 @default.
• W2164824871 creator A5039135644 @default.
• W2164824871 creator A5051584931 @default.
• W2164824871 creator A5063408023 @default.
• W2164824871 creator A5089590381 @default.
• W2164824871 date "1997-04-01" @default.
• W2164824871 modified "2023-10-16" @default.
• W2164824871 title "Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival." @default.
• W2164824871 cites W108407778 @default.
• W2164824871 cites W12947604 @default.
• W2164824871 cites W130907858 @default.
• W2164824871 cites W1553842116 @default.
• W2164824871 cites W1559835035 @default.
• W2164824871 cites W1562216281 @default.
• W2164824871 cites W1567820531 @default.
• W2164824871 cites W1939982746 @default.
• W2164824871 cites W1975733532 @default.
• W2164824871 cites W1988087441 @default.
• W2164824871 cites W1989724007 @default.
• W2164824871 cites W2000275836 @default.
• W2164824871 cites W2001124438 @default.
• W2164824871 cites W2004108504 @default.
• W2164824871 cites W2012903213 @default.
• W2164824871 cites W2039183466 @default.
• W2164824871 cites W2039397705 @default.
• W2164824871 cites W2060817789 @default.
• W2164824871 cites W2061798825 @default.
• W2164824871 cites W2077279071 @default.
• W2164824871 cites W2091279558 @default.
• W2164824871 cites W2098457595 @default.
• W2164824871 cites W2119738345 @default.
• W2164824871 cites W2268581826 @default.
• W2164824871 cites W2313250869 @default.
• W2164824871 cites W2330292521 @default.
• W2164824871 cites W2402156397 @default.
• W2164824871 cites W2411587487 @default.
• W2164824871 cites W2413031356 @default.
• W2164824871 cites W2415294652 @default.
• W2164824871 cites W2417404386 @default.
• W2164824871 cites W2438045793 @default.
• W2164824871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9815727" @default.
• W2164824871 hasPublicationYear "1997" @default.
• W2164824871 type Work @default.
• W2164824871 sameAs 2164824871 @default.
• W2164824871 citedByCount "109" @default.
• W2164824871 countsByYear W21648248712012 @default.
• W2164824871 countsByYear W21648248712013 @default.
• W2164824871 countsByYear W21648248712014 @default.
• W2164824871 countsByYear W21648248712015 @default.
• W2164824871 countsByYear W21648248712016 @default.
• W2164824871 countsByYear W21648248712017 @default.
• W2164824871 countsByYear W21648248712018 @default.
• W2164824871 countsByYear W21648248712019 @default.
• W2164824871 countsByYear W21648248712020 @default.
• W2164824871 countsByYear W21648248712021 @default.
• W2164824871 countsByYear W21648248712022 @default.
• W2164824871 countsByYear W21648248712023 @default.
• W2164824871 crossrefType "journal-article" @default.
• W2164824871 hasAuthorship W2164824871A5000409705 @default.
• W2164824871 hasAuthorship W2164824871A5001630082 @default.
• W2164824871 hasAuthorship W2164824871A5010151617 @default.
• W2164824871 hasAuthorship W2164824871A5039135644 @default.
• W2164824871 hasAuthorship W2164824871A5051584931 @default.
• W2164824871 hasAuthorship W2164824871A5063408023 @default.
• W2164824871 hasAuthorship W2164824871A5089590381 @default.
• W2164824871 hasConcept C121608353 @default.
• W2164824871 hasConcept C126322002 @default.
• W2164824871 hasConcept C134018914 @default.
• W2164824871 hasConcept C176674119 @default.
• W2164824871 hasConcept C185592680 @default.
• W2164824871 hasConcept C202751555 @default.
• W2164824871 hasConcept C2775930923 @default.
• W2164824871 hasConcept C2776575606 @default.
• W2164824871 hasConcept C2777982462 @default.
• W2164824871 hasConcept C2779013556 @default.
• W2164824871 hasConcept C2780804394 @default.
• W2164824871 hasConcept C51296783 @default.
• W2164824871 hasConcept C530470458 @default.
• W2164824871 hasConcept C55493867 @default.
• W2164824871 hasConcept C71924100 @default.
• W2164824871 hasConcept C90924648 @default.
• W2164824871 hasConceptScore W2164824871C121608353 @default.
• W2164824871 hasConceptScore W2164824871C126322002 @default.
• W2164824871 hasConceptScore W2164824871C134018914 @default.
• W2164824871 hasConceptScore W2164824871C176674119 @default.
• W2164824871 hasConceptScore W2164824871C185592680 @default.
• W2164824871 hasConceptScore W2164824871C202751555 @default.
• W2164824871 hasConceptScore W2164824871C2775930923 @default.
• W2164824871 hasConceptScore W2164824871C2776575606 @default.
• W2164824871 hasConceptScore W2164824871C2777982462 @default.
• W2164824871 hasConceptScore W2164824871C2779013556 @default.
• W2164824871 hasConceptScore W2164824871C2780804394 @default.
• W2164824871 hasConceptScore W2164824871C51296783 @default.
• W2164824871 hasConceptScore W2164824871C530470458 @default.

• next